MedPath

A Capsular Incision and Biochemical Recurrence After Radical Perineal Prostatectomy

Completed
Conditions
Radical Perineal Prostatectomy
Registration Number
NCT00748514
Lead Sponsor
Samsung Medical Center
Brief Summary

To evaluate the impact of capsular incisions on biochemical recurrence (BCR) and the potential risk factors of capsular incisions.

Detailed Description

The pathological classification of the prostate following radical prostatectomy provides important prognostic information; an accurate pathology report is the cornerstone to cancer treatment and follow-up. In addition to the preoperative serum PSA, Gleason score on pathology specimens, seminal vesicle invasion and lymph node status, and a positive surgical margin with extraprostatic extension (EPE) are significant predictors of clinical and biochemical recurrence. However, the prognostic implication of a capsular incision, a tumor extending to the inked margins without a histologically documented EPE, remains to be defined.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
266
Inclusion Criteria
  • pathologically proven prostate cancer
  • follow-up for at least 6 months
Exclusion Criteria
  • insufficient biopsy data
  • seminal vesicle invasion or lymph node involvement on pathology
  • neoadjuvant or adjuvant therapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
biochemical recurrence of prostate cancerupto the final date of study
Secondary Outcome Measures
NameTimeMethod
risk factors for capsular incisionsat surgery

Trial Locations

Locations (1)

Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath